Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Personalised medicine can improve treatment, but access still an issue

Personalised medicine can improve treatment, but access still an issue

Barriers to access could harm uptake of potentially transformative therapies. Personalised medicines such as gene therapies may improve identification of optimal treatment but gaining access to these treatments still poses an ... For example, NHS England

Latest news

  • Greater Manchester backs move to outcome-based payment Greater Manchester backs move to outcome-based payment

    able to access new and innovative medicines as early as possible and delivering better value for money.”. ... We’re set to see more personalised medicines being launched over the next few years, so additional data will help ensure those treatments

  • CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL

    Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE said: “Recommending another revolutionary CAR T-cell therapy for adults with lymphoma represents a step forward for personalised medicine. ... Providing the latest cutting

  • Hancock says UK genome service is now ‘rolling out’ Hancock says UK genome service is now ‘rolling out’

    The news was welcomed by Mike Thompson, chief executive of the Association of the British Pharma Industry (ABPI), who said: “The health secretary’s focus on earlier diagnosis and more personalised ... medicines for cancer and rare diseases is great

  • Novartis cuts manufacturing jobs in Switzerland and UK Novartis cuts manufacturing jobs in Switzerland and UK

    Chief executive Vas Narasimhan says the cuts are part of Novartis’ strategy to move away from high-volume drug production towards more specialised and personalised medicines.

  • UK pharma to work with innovation network on NHS uptake UK pharma to work with innovation network on NHS uptake

    The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of  medicines and other 'biomedical innovations' ... These areas include economic growth, digital

More from news
Approximately 13 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • The dawn of a new era in medical education The dawn of a new era in medical education

    By Annlouise Pendse. We are living in a pivotal moment in medical history. The first wave of personalised medicines is now available and is changing the way diseases are identified and ... delivering often complex personalised medicine.

  • The first, my last, my everything The first, my last, my everything

    This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... We need a better understanding of patients. We’re heading rapidly towards personalised medicines, yet we’re still not personalising the value that we

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    We can then make sure personalised medicine treatment is targeted to the individual so they get the best treatment at the right point in time. ... Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide

  • Cell and gene therapy Cell and gene therapy

    In the case of a personalised therapy like CAR-T, the cost of the raw materials, the components and the labour that goes into manufacturing, testing and logistics are all for ... For traditional biopharmaceutical products one batch equals many doses,

More from intelligence
Approximately 4 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • 'Fake news': battling misinformation in healthcare

    As the pharmaceutical landscape becomes more complex and as personalised and precision medicines emerge, these stories are increasingly impacting patients and healthcare professionals.

  • Mastering the precision medicine opportunity

    Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.

  • Medopad: the up and coming unicorn transforming remote patient monitoring

    The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Healthcare is becoming more precise

  • Medicines personalised for Tom, Dick and Harry

    And so enters the concept of personalised medicine with the aim of providing treatments to ever-shrinking populations of high responders. ... Perhaps more radical ideas need to be considered to deliver personalised medicine that is both equitable and

  • Being Human - The healthcare angle

    The industry is busily developing innovative, often personalised medicines, but we’re under unprecedented scrutiny.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics